Skip to main content
. 2021 Jul 17;11(7):941. doi: 10.3390/brainsci11070941

Table 1.

Demographics and clinical characteristics.

Characteristics Clinical High Risk
(N = 13)
Healthy Controls
(N = 30)
t/χ2 p
Gender (male/female) 11/2 19/11 1.948 0.163
Marital status (Mar/S) 1/12 2/28 0.009 0.926
Age (M/SD) 22.2/4.0 21.8/3.7 −0.330 0.745
Parental NS-SEC (M/SD) 3.54/0.88 3.03/1.38 −1.444 0.158
Cannabis use (Y/N) 6/7 1/29 4.926 0.026
Antidepressant use (Y/N) 3/10 -
Benzodiazepine use (Y/N) 2/11 -
Antipsychotic use (Y/N) 1/12 -
SOPS, total (M/SD) 8.4/5.0 -
CAST, total (M/SD) 11.4/7.8 6.2/0.8 −2.20 0.052
Audit—C, total (M/SD) 5.5/3.8 5.9/2.5 0.281 0.783
SOFAS (M/SD)
APS/BLIPS
Converted (Y/N)
67.7/9.5
13/0
3/10
82.7/3.8

6.267

0.000

Chi-squared analyses for categorical variables and independent t-tests for continuous variables were used to calculate p-values for differences between groups. Mar—married, S—single, M—mean, SD—standard deviation, NS-SEC—National Statistics Socio-economic Classification, Y—yes, N—no, SOPS—scale of prodromal symptoms, CAST—Cannabis Abuse Screening Test, AUDIT—C—Alcohol Use Disorders Identification Test—Concise, SOFAS—Social and Occupational Functioning Assessment Scale, APS—attenuated psychotic syndrome, BLIPS—brief and limited intermittent psychosis.